Table 2.
RMP (mV) | IJP amplitude (mV) | IJP duration (ms) | |
---|---|---|---|
Control n=4 | −41.0±3.3 | 6.6±1.5 | 366±61 |
Apamin (300 nM) | −38.4±3.0 | 2.4±0.5* | 518±97 |
Apamin (300 nM)+ L-NAME (200 μM) | −35.0±3.9 | 1.8±0.4 | N/M |
Abbreviations: LES, lower oesophageal sphincter; L-NAME, N-nitro-L-arginine methyl ester; N/M, not measured or not measurable; RMP, resting membrane potential.
*P<0.05 before and after drug application.
‘Control' represents results obtained in the presence of atropine (3 μM), guanethidine (3 μM) and substance P (1 μM).